Baxter’s Sodium Chloride Injections Dogged Once More by Recall

Insects found in IV solutions have forced Baxter International to voluntarily recall two lots of product, the firm’s seventh recall of an intravenous solution since December 2013.

Sodium chloride injection is again the focus of the recall — as it has been in five other of the seven particulate-induced recalls. Both lots involve 0.9 percent sodium chloride injection, one in a Viaflex plastic container and the other in a Mini-Bag Plus container.

In both cases, the particulates were discovered prior to administration and noted in customer complaints, Baxter says. No related adverse events have been reported.

The lots were distributed to customers and distributors in the U.S. between Oct. 7, 2014, and July 14, 2015.

In April, Baxter was forced to recall 15 lots, or roughly 237,000 units, of sodium chloride because of particulates. Like the earlier recall, this one comes in the midst of a nationwide saline shortage.

Baxter did not return a request for comment by press time. View the recall notice at www.fdanews.com/07-21-15-BaxerRecall.pdf . — Kellen Owings